U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Michael Todd Beauty LP - 04/05/2017
  1. Warning Letters


Michael Todd Beauty LP

Michael Todd Beauty LP

United States

Issuing Office:

United States



Black HHS-Blue FDA Logo



Florida District
555 Winderley Place, Suite 200
Maitland, Florida 32751 

April 05, 2017


Lewis Hendler, Chairman
Michael Todd Beauty LP
648 SW Port St. Lucie Blvd
Port St. Lucie, FL 34953

Dear Mr. Hendler:

The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter [FLA-16-18, July 18, 2016]. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.


Susan M. Turcovski
Director, Florida District

Mark C. Levy, Esq.
Eckert Seamans Cherin & Mellott, LLC
Two Liberty Place
50 South 16th Street 22nd Floor
Philadelphia, PA 19102

Back to Top